Motoji Kitagawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Motoji Kitagawa has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Tetsuo Hayakawa
Department of Internal Medicine, Nagoya University School of Medicine, Nagoya, Japan
8 shared publications Hiroshi Ishiguro
3 shared publications- Satoru Naruse
Department of Internal Medicine, Nagoya University School of Medicine, Nagoya, Japan
3 shared publications Shinobu Hayakawa
3 shared publications- Chun Xiang Jin
First Clinical College of Norman Bethune Medical Division, Jilin University, Changchun, China
2 shared publications Noriyuki Tatemichi
Department of Clinical Chemistry, Maruko Pharmaceutical Co., Ltd., Kasugai, Japan
2 shared publications
Latest Publications
- 18 May 2009
- Vol. 10 (3) , 237-41
Lactoferrin in chronic pancreatitis.
The present review is focused on the clinical significance of lactoferrin in pancreatic secretions and stone formation in chronic pancreatitis, and of serum anti-lactoferrin antibody in autoimmune pancreatitis. Lactoferrin secretion is increased in pancreatic secretions in calcified and non-calcified chronic pancreatitis. Lactoferrin, pancreatic stone protein and trypsin are present in pancreatic stones. We cannot conclude which protein is more important for the precipitate and stone formation. The presence of antilactoferrin antibody has been reported in serum in autoimmune diseases, such as autoimmune pancreatitis. The coincidental appearance of autoimmune pancreatitis with extrapancreatic autoimmune diseases strongly suggests a common autoimmune mechanism and lactoferrin is a candidate antigen. Lactoferrin may play an important role as a precipitate protein in pancreatic stone formation in chronic pancreatitis and as an autoantigen in autoimmune pancreatitis. Further studies are required to better understand the role of lactoferrin.
- 18 May 2009
- Vol. 10 (3) , 237-41
Lactoferrin in chronic pancreatitis.
The present review is focused on the clinical significance of lactoferrin in pancreatic secretions and stone formation in chronic pancreatitis, and of serum anti-lactoferrin antibody in autoimmune pancreatitis. Lactoferrin secretion is increased in pancreatic secretions in calcified and non-calcified chronic pancreatitis. Lactoferrin, pancreatic stone protein and trypsin are present in pancreatic stones. We cannot conclude which protein is more important for the precipitate and stone formation. The presence of antilactoferrin antibody has been reported in serum in autoimmune diseases, such as autoimmune pancreatitis. The coincidental appearance of autoimmune pancreatitis with extrapancreatic autoimmune diseases strongly suggests a common autoimmune mechanism and lactoferrin is a candidate antigen. Lactoferrin may play an important role as a precipitate protein in pancreatic stone formation in chronic pancreatitis and as an autoantigen in autoimmune pancreatitis. Further studies are required to better understand the role of lactoferrin.
- 9 July 2007
- Vol. 8, 476-8
Antiproteases and the pancreas: basic and clinical update. Introduction.
- 9 July 2007
- Vol. 8, 538-44
Antiproteases and the pancreas: basic and clinical update. Conclusion remarks.
- 9 July 2007
- Vol. 8, 538-44
Antiproteases and the pancreas: basic and clinical update. Conclusion remarks.
- Open Access
- 1 September 2003
- Published by Wiley in The Journal of Physiology
- Vol. 551 (3) , 917-926
Ethanol induces fluid hypersecretion from guinea-pig pancreatic duct cells
- 1 September 2003
- Published by Wiley in The Journal of Physiology
- Vol. 551 (3) , 917-926
Open AccessEthanol induces fluid hypersecretion from guinea-pig pancreatic duct cells
- 1 March 2002
- Vol. 3 (2) , 54-61
Pancreatic stone protein of pancreatic calculi in chronic calcified pancreatitis in man.
The role of protein components of pancreatic secretions has been controversial in pancreatic stone formation. To study the lithogenic role of pancreatic stone protein and lactoferrin in stone formation in chronic pancreatitis. Pancreatic stones were collected from 13 patients with alcoholic (n=6) and nonalcoholic (n=7) chronic calcified pancreatitis. Pancreatic stone extracts were analyzed for pancreatic stone protein and lactoferrin using enzyme immunoassay. The localization of pancreatic stone protein immunoreactivity in the stone was observed using immunogold staining and scanning electron microscopy. Immunoreactivities for pancreatic stone protein were detected in the stones from all 13 patients with chronic calcified pancreatitis and for lactoferrin in the stones from five of the 13 patients. Pancreatic stone protein immunoreactivity distributed diffusely from the center to the periphery of the pancreatic stones. Involvement of pancreatic stone protein seems to be constant from the initial step of the stone formation to subsequent steps of the stone growth. However, pancreatic stone protein is only one of the precipitating proteins in pancreatic secretions such as lactoferrin, trypsinogen, etc.
- 1 March 2002
- Vol. 3 (2) , 54-61
Pancreatic stone protein of pancreatic calculi in chronic calcified pancreatitis in man.
The role of protein components of pancreatic secretions has been controversial in pancreatic stone formation. To study the lithogenic role of pancreatic stone protein and lactoferrin in stone formation in chronic pancreatitis. Pancreatic stones were collected from 13 patients with alcoholic (n=6) and nonalcoholic (n=7) chronic calcified pancreatitis. Pancreatic stone extracts were analyzed for pancreatic stone protein and lactoferrin using enzyme immunoassay. The localization of pancreatic stone protein immunoreactivity in the stone was observed using immunogold staining and scanning electron microscopy. Immunoreactivities for pancreatic stone protein were detected in the stones from all 13 patients with chronic calcified pancreatitis and for lactoferrin in the stones from five of the 13 patients. Pancreatic stone protein immunoreactivity distributed diffusely from the center to the periphery of the pancreatic stones. Involvement of pancreatic stone protein seems to be constant from the initial step of the stone formation to subsequent steps of the stone growth. However, pancreatic stone protein is only one of the precipitating proteins in pancreatic secretions such as lactoferrin, trypsinogen, etc.
- 1 January 1996
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 10 (5) , 239-242
Optimal conditions for collection of blood samples for assay of α2‐macroglobulin trypsin complex‐like substance (MTLS)
- 1 January 1996
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 10 (5) , 239-242
Optimal conditions for collection of blood samples for assay of α2‐macroglobulin trypsin complex‐like substance (MTLS)
- 1 January 1993
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 7 (6) , 365-370
Enzyme immunoassay and characterization of pancreatic stone proteins in human urine
- 1 January 1993
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 7 (6) , 365-370
Enzyme immunoassay and characterization of pancreatic stone proteins in human urine